Revenue
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
CorMedix Inc. (CRMD)
Price$8.43Cached quote
Net income
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $311.7M | $43.5M | $0 | $65,408 | $190,936 | $239,231 | $283,266 | $429,797 | $329,327 | $224,105 | $210,130 | $189,274 | $2,001 | $0 | — | — | — | — | — |
| Gross profit | $275.7M | $40.3M | $0 | $61,674 | $41,998 | $34,385 | −$89,968 | $33,011 | $214,363 | −$142,568 | −$108,588 | −$256,525 | −$199,604 | $0 | — | — | — | — | — |
| Gross margin | 88.46% | 92.66% | — | 94.29% | 22.00% | 14.37% | −31.76% | 7.68% | 65.09% | −63.62% | −51.68% | −135.53% | −9,975.21% | — | — | — | — | — | — |
| Research & development | $19.3M | $3.9M | $13.2M | $10.7M | $13.1M | $13.4M | $11.1M | $18.8M | $24.5M | $15.7M | $6.3M | $1.3M | $1.2M | $1.1M | $4.1M | $5.5M | — | — | — |
| Operating expenses | $125.6M | $62.6M | $49.0M | $30.7M | $29.5M | $27.3M | $20.9M | $26.9M | $33.1M | $24.6M | $16.5M | $8.6M | $4.7M | $3.0M | $7.2M | $8.5M | — | — | — |
| Operating income | $150.1M | −$22.4M | −$49.0M | −$30.6M | −$29.4M | −$27.2M | −$21.0M | −$26.9M | −$32.9M | −$24.8M | −$16.7M | −$8.9M | −$4.9M | −$3.0M | −$7.2M | −$8.5M | — | — | — |
| Operating margin | 48.17% | −51.43% | — | −46,819.91% | −15,417.51% | −11,378.44% | −7,416.31% | −6,250.44% | −9,997.39% | −11,048.80% | −7,925.56% | −4,703.30% | −245,646.93% | — | — | — | — | — | — |
| EBITDA | $164.7M | −$22.0M | −$48.9M | −$30.5M | −$29.4M | −$27.1M | −$20.9M | −$26.8M | −$32.9M | −$24.7M | −$16.6M | −$8.9M | −$4.9M | −$3.0M | −$7.2M | −$8.5M | — | — | — |
| EBITDA margin | 52.83% | −50.71% | — | −46,690.54% | −15,385.10% | −11,324.95% | −7,390.44% | −6,233.17% | −9,986.19% | −11,037.38% | −7,918.38% | −4,695.33% | −245,389.01% | — | — | — | — | — | — |
| Net income | $163.1M | −$17.9M | −$46.3M | −$29.7M | −$28.2M | −$22.0M | −$16.4M | −$26.8M | −$33.0M | −$24.6M | −$18.2M | −$20.5M | −$9.1M | −$3.4M | −$6.7M | −$10.9M | −$8.1M | −$9.0M | −$7.2M |
| Net profit margin | 52.31% | −41.24% | — | −45,409.90% | −14,774.70% | −9,207.70% | −5,801.29% | −6,242.40% | −10,023.45% | −10,996.46% | −8,655.37% | −10,806.25% | −456,426.69% | — | — | — | — | — | — |
| Basic EPSper basic share | $2.25 | -$0.30 | -$0.91 | -$0.74 | -$0.75 | -$0.77 | -$1.80 | -$1.51 | -$0.60 | -$0.65 | -$0.58 | -$0.96 | -$0.69 | -$0.30 | -$0.58 | -$1.15 | — | — | — |
| Diluted EPSper diluted share | $2.04 | -$0.30 | -$0.91 | -$0.74 | -$0.75 | -$0.77 | -$1.80 | -$1.51 | -$0.60 | -$0.65 | -$0.58 | -$0.96 | -$0.69 | -$0.30 | -$0.58 | -$1.15 | — | — | — |
Owners
Reported shareholders
8.14%of listed shares
BlackRock, Inc.6.32M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 8.14%6.32M shares |
Deep Track Capital, LP | 8.08%6.27M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 4.04%3.14M shares |
STATE STREET CORP | 2.98%2.32M shares |
ROYCE & ASSOCIATES LP | 2.80%2.18M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.51%1.95M shares |
UBS Group AG | 2.42%1.88M shares |
OBERWEIS ASSET MANAGEMENT INC/ | 1.70%1.32M shares |
Alyeska Investment Group, L.P. | 1.09%850K shares |
MARSHALL WACE, LLP | 1.00%779.54K shares |
Todisco Joseph | ≈1.00%774.75K shares |
NORTHERN TRUST CORP | 0.97%756.43K shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 0.91%708.6K shares |
Pacer Advisors, Inc. | 0.82%633.98K shares |
HRT FINANCIAL LP | 0.81%625.56K shares |
Trexquant Investment LP | 0.80%623.8K shares |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.80%618.17K shares |
ARMISTICE CAPITAL, LLC | 0.64%500K shares |
VANGUARD FIDUCIARY TRUST CO | 0.62%484.32K shares |
GOLDMAN SACHS GROUP INC | 0.60%466.39K shares |
Percentages use 77.67M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jan 21, 2026Form 4 · 10b5-1 | Dillione JanetDirector | SellCommon Stock | 10.0K | $6.88 | $68.8K | 38.5K |
| Dec 30, 2025Form 4 · 10b5-1 | DUNTON ALAN WDirector | SellCommon Stock | 20.0K | $13.00 | $260.0K | 40.3K |
| Dec 18, 2025Form 4 · 10b5-1 | Todisco JosephChief Executive Officer | SellCommon Stock | 30.0K | $12.00 | $360.0K | 509.5K |
| Dec 9, 2025Form 4 · 10b5-1 | Dillione JanetDirector | SellCommon Stock | 34.0K | $12.00 | $408.0K | 48.5K |
| Dec 9, 2025Form 4 | Lefkowitz Steven WDirector | SellCommon Stock | 40.0K | $11.88 | $475.2K | 80.5K |